As of Feb. 21, the FDA will lift pandemic-era flexibility for veterinary telemedicine and resume enforcement of the federal requirement that animals have an in-person examination or site visit to establish a veterinarian-client-patient relationship for certain activities, such as extralabel drug use and release of veterinary feed directives. Under the rule, a VCPR cannot be established via telemedicine, though an existing VCPR may include telemedicine between medically appropriate examinations and site visits.
